A caveat to the OPTIMA-AF trial: event rates were much lower than expected, complicating interpretation.
NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral…
Category: 6. Health
-
TOP: Does Liberal Transfusion Post Surgery Improve Outcomes in Patients at High CV Risk?
A liberal transfusion strategy following major vascular or general surgery did not significantly improve outcomes at 90 days post procedure in patients at high risk of a cardiac event when compared to a restrictive strategy, according to…
Continue Reading
-
Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease
Research Highlights:
- Earlier blood transfusion after major surgery – when hemoglobin was below 10 g/dL rather than beow 7 g/dl – did not affect the risk of severe complications, such as death, heart attack, need for a heart…
Continue Reading
-
The Ghost Plants of Japan: How they survive where sunlight never reaches |
Deep in Japan’s shaded forests, you might spot ghostly white plants that seem almost otherworldly. These ghost plants of Japan survive in areas where sunlight barely reaches the forest floor. Unlike green plants, they lack chlorophyll and do…
Continue Reading
-
ABC8 2025 Day 3: A Decade of Progress, Unity, and Vision in Advanced Breast Cancer Care
The final day of the 8th Advanced Breast Cancer International Consensus Conference, ABC8 2025 Day 3 marked the culmination of three transformative days of scientific dialogue, patient advocacy, and collective purpose. On…
Continue Reading
-
CRISPR Gene Editing Therapy CTX310 Lowers LDL-C and Triglycerides in Lipid Disorders
CTX310, a one-time CRISPR-Cas9 gene-editing therapy, has safely reduced LDL cholesterol and triglycerides in adult patients with difficult-to-treat
lipid disorders .1Presented at the
American Heart Association’s Scientific Sessions 2025 in New…Continue Reading
-
New Trials Redefine Antithrombotic and Stroke Prevention Strategies in AFib
Four major studies presented at AHA 2025 are reshaping strategies for managing atrial fibrillation (AFib) in complex clinical scenarios. OCEAN addresses whether ongoing anticoagulation is necessary after successful catheter ablation, offering…
Continue Reading
